Mortality risk among sulfonylureas: a systematic review and network meta-analysis

SH Simpson, J Lee, S Choi, B Vandermeer… - The lancet Diabetes & …, 2015 - thelancet.com
Background Sulfonylureas are common second-line options for management of type 2
diabetes; however, they are associated with a higher risk of cardiovascular events compared …

Gaps and barriers in the control of blood glucose in people with type 2 diabetes

L Blonde, P Aschner, C Bailey, L Ji… - Diabetes and …, 2017 - journals.sagepub.com
Background: Glycaemic control is suboptimal in a large proportion of people with type 2
diabetes who are consequently at an increased and avoidable risk of potentially severe …

The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial

RT Tsuyuki, YN Al Hamarneh, CA Jones… - Journal of the American …, 2016 - jacc.org
Background: Despite the cardiovascular disease (CVD) risk associated with hypertension,
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and …

Specialist‐led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC D iabetes R …

R Aronson, N Orzech, C Ye, R Goldenberg… - Journal of …, 2016 - Wiley Online Library
摘要背景当前这项研究的目的是在专科诊所接受治疗的2 型糖尿病患者中调查与血糖控制相关
的患者特征. 方法检索文献后辨别出数据库中记录了专科医生治疗效果的糖尿病登记表 …

The systematic design of a behavioural mobile health application for the self-management of type 2 diabetes

S Goyal, P Morita, GF Lewis, C Yu, E Seto… - Canadian journal of …, 2016 - Elsevier
Patients with diabetes often face serious complications due to limited self-management
skills, the inability to adhere to care regimens, and psychosocial factors. Although regular …

Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: a cross-sectional study

R Hao, T Myroniuk, T McGuckin, D Manca… - BMC Primary …, 2022 - Springer
Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-
1 receptor agonists (GLP-1RA) have shown benefits in patients with diabetes and …

[HTML][HTML] Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?

RE Gilbert - Kidney international, 2014 - Elsevier
The proximal tubule's sodium–glucose linked transporter-2 (SGLT2) accounts for the vast
majority of glucose reabsorption by the kidney. Its selective inhibition, accordingly, leads to …

[HTML][HTML] Semaglutide: review and place in therapy for adults with type 2 diabetes

RM Goldenberg, O Steen - Canadian journal of diabetes, 2019 - Elsevier
Guidelines increasingly highlight the importance of multifactorial management in type 2
diabetes, in contrast to the more traditional focus on glycemic control. Semaglutide, a …

Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial

LA Leiter, H Teoh, E Braunwald, O Mosenzon… - Diabetes …, 2015 - Am Diabetes Assoc
OBJECTIVE To examine the safety and cardiovascular (CV) effects of saxagliptin in the
predefined elderly (≥ 65 years) and very elderly (≥ 75 years) subpopulations of the …

Exploring interprofessional collaboration during the integration of diabetes teams into primary care

E Gucciardi, S Espin, A Morganti, L Dorado - BMC family practice, 2016 - Springer
Background Specialised diabetes teams, specifically certified nurse and dietitian diabetes
educator teams, are being integrated part-time into primary care to provide better care and …